Please login to the form below

Not currently logged in

Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue

Eli Lilly new HQBamlanivimab is being studied in a number of additional ongoing trials

Bayer pays an initial $2bn for gene therapy firm AskBio

Bayer symbolAcquisition will expand Bayers’s pipeline with preclinical/clinical candidates

Researchers say COVID-19 antibody levels have fallen rapidly in the UK

Coronavirus newNumber of people testing positive for antibodies fell by 26.5% between June and September

Both AZ and J&J set to resume US COVID-19 vaccine trials

Vaccine vialBoth companies paused their trials after separate participant illness events

Caroline Gosling

Q&A: Caroline Gosling

PME interviews Rubica's Director of Culture & Engagement

Isabel Gibson

Q&A: Isabel Gibson

PME interviews W2O ISO's Managing Director

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Bombarded with information – the challenge of crowded digital channels

Chris Ross explores the pursuit of communications excellence in a world of noise

PME oct cover

Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm

Perlmutter is set to join the board of AI drug discovery biotech Insitro

Roger Perlmutter

Bayer's drop of the future

Digital health isn’t always about digital

Bayer OneDrop

90TEN bolsters senior management team

Agency establishes new role of head of behavioural science


Preparing for online interviews and remote working

As the world changes to social distancing, here are some pointers for employees to think about

Digital Intelligence blog pharma

COVID-19 Updates and Daily News

Featured jobs


Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...